<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>CancerCompass Message Board:  Use of Proleukin or Interleukin L2  in association with Taxotere and Cisplatin</title>
    <description>CancerCompass message board discussion started by pablo g. on 7/15/2003</description>
    <link>http://www.cancercompass.com/message-board/message/all,658,0.htm</link>
    <pubDate>Sat, 11 Oct 2008 00:00:00 GMT</pubDate>
    <lastBuildDate>Sat, 11 Oct 2008 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title> Use of Proleukin or Interleukin L2  in association with Taxotere and Cisplatin</title>
      <description>My brother recently diagnosed with NSCLC Stage 3B...Started therapy with taxotere and cisplatin 21 day intervals and in between Proleukin...There seems to be some controversy on this subject.
Any comments?  Thank you
</description>
      <author>pablo g.</author>
      <pubDate>Tue, 15 Jul 2003 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>